Traws Pharma, Inc. — Director's Dealing 2023

Aug 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2023-08-02

Reporting Person: Guerin Mark Patrick (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-02	Common Stock	M	4750	—	Acquired	26866	Direct
2023-08-03	Common Stock	F	1422	$1.02	Disposed	25444	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-02	Restricted Stock Units	$	M	4750	Disposed		Common Stock (4750)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.